DVLT

Corexa Health's three divisions - pharmacy, distribution, and tech & hub - positioned to serve the emerging compounded peptide market TAMPA, FL / ACCESS Newswire / October 16, 2026 / DataMeds AI, Inc. (NASDAQ:MEDS) ("DataMeds AI," "DataMEDS SI," "DataMEDS," or the "Company"), a healthcare company leveraging its Health IT and physical infrastructure together with its super intelligence platform EinsteinRx™ and smart contracts platform PharmacyChain™, today applauded the issuance of a new policy proposal by the U.S. Food and Drug Administration (FDA) entitled "Interim Access Policy for Compounding Using Certain Peptides." The new proposed policy comes less than three months following the

8-K - Datavault AI Inc. (0001682149) (Filer)

8-K - Datavault AI Inc. (0001682149) (Filer)

Allowed patent application covers asset valuation, tokenization, transaction verification, and blockchain-enabled marketplaces as a new federal framework opens the door to on-chain trading of tokenized stocks PHILADELPHIA, PA / ACCESS Newswire / October 15, 2026 / Datavault AI Inc. ("Datavault AI" or the "Company") (NASDAQ:DVLT), a provider of data monetization, credentialing, digital engagement, and real-world asset ("RWA") tokenization technologies, today announced that the U.S. Patent and Trademark Office has issued a notice of allowance for its Method and System for Data Futures Platform patent application (U.S. Patent Application No. 17/441,847), and highlighted the relevance of t

Platform to be integrated into Health Lives Here app as a subscription offering TAMPA, FL / ACCESS Newswire / October 14, 2026 / DataMeds AI, Inc. (NASDAQ:MEDS) ("DataMeds AI," "DataMEDS SI," "DataMEDS," or the "Company"), a healthcare company leveraging its Health IT and physical infrastructure together with its super intelligence platform EinsteinRx™ and smart contracts platform PharmacyChain™, today announced that it has entered into an exclusive license, revenue sharing and marketing agreement with REBOOT Health AI, Inc. ("REBOOT") for Direct-to-Consumer (DTC) rights in the United States to REBOOT's proprietary care management platform. The Companies will work together to tailor th

Tirman, through his family office Abri Capital Ltd., holds 26 million DVLT shares and brings over 35 years of international investment management and corporate restructuring experience to the Company Datavault AI Inc. ("Datavault AI" or the "Company") (NASDAQ:DVLT), an Artificial Intelligence Platform ("AIP") company providing data monetization, credentialing, and real-world asset ("RWA") tokenization, today announced the appointment of Jeffrey Tirman to its Board of Directors, effective as of October 12, 2026. Mr. Tirman was designated by NYIAX, Inc. ("NYIAX") in connection with Datavault AI's recently completed acquisition of NYIAX, and he previously served on NYIAX's board of directors

CEO Nathaniel T. Bradley to present on tokenization capabilities Today, October 13, at 3:45 p.m. PT at the Bellagio in Las Vegas LAS VEGAS, NV AND PHILADELPHIA, PA / ACCESS Newswire / October 13, 2026 / Datavault AI Inc. ("Datavault AI" or the "Company") (NASDAQ:DVLT), a provider of data monetization, credentialing, digital engagement, and real-world asset ("RWA") tokenization technologies, today announced that it will attend Mass Torts Made Perfect, the national mass tort conference taking place October 13-15, 2026 at the Bellagio in Las Vegas, where CEO Nathaniel T. Bradley will discuss Datavault AI's tokenization capabilities for Tort litigation during a presentation at 3:45 p.m. PT

Leading Health IT Company has Implemented Cost Control Measures and Refocused Remaining Workforce Towards ChemoFx® Commercialization with Hospital Systems, HMOs, GPOs and Cancer Centers TAMPA, FL / ACCESS Newswire / October 13, 2026 / DataMeds AI, Inc. (NASDAQ:MEDS) ("DataMeds AI," "DataMEDS SI," "DataMEDS," or the "Company"), a healthcare company leveraging its Health IT and physical infrastructure together with its super intelligence platform EinsteinRx™ and smart contracts platform PharmacyChain™, today announced that it has implemented cost control measures, primarily through reductions in corporate management positions, to focus the workforce spend on commercializing ChemoFx® as a

Humana adds ChemoFx® to its Medicaid Pharmacogenomics Testing coverage policy TAMPA, FL / ACCESS Newswire / October 12, 2026 / DataMeds AI, Inc. (NASDAQ:MEDS) ("DataMeds AI," "DataMEDS SI," "DataMEDS," or the "Company"), a healthcare company vertically integrating its Health IT and physical infrastructure together with its super intelligence platform EinsteinRx™ and smart contracts platform PharmacyChain™, today announced that its recently acquired CLIA-certified precision oncology laboratory subsidiary Helomics Corporation has received a Medicaid coverage determination in gynecologic cancers for the ChemoFx® Assay, a commercially available chemoresponse test that measures how a patien

Datavault AI Inc. ("Datavault AI" or the "Company") (NASDAQ:DVLT), an Artificial Intelligence Platform ("AIP") company providing data monetization, credentialing, digital engagement, real-world asset ("RWA") tokenization and spatial audio technologies, is excited to announce its participation in the upcoming 2026 Maxim Growth Summit, taking place from October 12th to 14th at The Hard Rock Hotel NYC. This prestigious event brings together industry leaders, innovators, and premier institutions to explore the latest trends and advancements across several industries.Brett Moyer, Chairman and Chief Financial Officer, will be meeting with institutional investors in one-on-one sessions and engaging

3 - Datavault AI Inc. (0001682149) (Issuer)

8-K - Datavault AI Inc. (0001682149) (Filer)

Former PwC Partner brings more than 30 years of global financial leadership, corporate governance, SEC reporting and M&A experienceHardt to serve on the Board's Audit Committee and Nominating and Corporate Governance CommitteeDatavault AI Inc. ("Datavault AI" or the "Company") (NASDAQ:DVLT), an Artificial Intelligence Platform ("AIP") company providing data monetization, credentialing, digital engagement, real-world asset ("RWA") tokenization and spatial audio technologies, today announced the appointment of Christopher R. Hardt to its board of directors as an independent director, effective as of October 3, 2026. Hardt was designated by NYIAX, Inc. ("NYIAX") in connection with Datavault AI'

Healthcare IT Company and its Subsidiary Undertake Action Following US Government's Updated Nomenclature TAMPA, FL / ACCESS Newswire / October 5, 2026 / DataMeds AI, Inc. (NASDAQ:MEDS) ("DataMeds AI," "DataMEDS SI," "DataMEDS," or the "Company"), a healthcare company leveraging its Health IT and physical infrastructure together with its artificial intelligence platform EinsteinRx™ and smart contracts platform PharmacyChain™, today announced that it has filed DBAs for 'DataMEDS SI' and 'Corexa Health SI'. The Company also reminded shareholders of record as of the close of business on August 7, 2026 (the "Record Date") that the previously announced distribution (the "Distribution") of Dr

NEW YORK CITY, NY / ACCESS Newswire / October 2, 2026 / Levi & Korsinsky, LLP reminds purchasers of Datavault AI Inc. (NASDAQ:DVLT) securities of a pending securities class action on behalf of investors who acquired shares between September 4, 2024 and October 30, 2025. See if you could be eligible to recover. You may also contact Joseph E. Levi, Esq. at jlevi@levikorsinsky.com or ☎(212) 363-7500.DVLT shares fell $0.49 per share, or 19.44%, to close at $2.03 on October 31, 2025. Investors have until October 5, 2026 to seek lead plaintiff status.The Alleged Minimal-Activity Data ExchangeA data exchange generates revenue only when data actually changes hands. The Company told investors it took

Session to debut the first official XRP Seoul commemorative token, powered by ADIO® tone-to-token technology, and demonstrate unified valuation, credentialing, and verified metadata for real-world assets PHILADELPHIA, PA / ACCESS Newswire / October 2, 2026 / Datavault AI Inc. ("Datavault AI" or the "Company") (NASDAQ:DVLT), a provider of data monetization, credentialing, digital engagement, and real-world asset ("RWA") tokenization technologies, today announced that Nathaniel T. Bradley, CEO of Datavault AI, will present "Operating System for Tokenized Assets" at XRP Seoul 2026 on Oct. 3, 2026, at 3:05 p.m. KST at the Grand Hyatt Seoul in Seoul, South Korea. In the session, Bradley wil

September 2026 revenue up more than 66 percent from July 2026 with expansion of retail customer base and Tollo Health pharmaceutical-adjunct product launches TAMPA, FL / ACCESS Newswire / October 1, 2026 / DataMeds AI, Inc. (NASDAQ:MEDS) ("DataMeds AI," "DataMEDS," or the "Company"), a healthcare company leveraging its Health IT and physical infrastructure together with its artificial intelligence platform EinsteinRx™ and smart contracts platform PharmacyChain™, today provided a revenue update on Corexa Pharmacy, a division of its wholly owned subsidiary Corexa Health.Corexa Pharmacy recorded preliminary, unaudited revenue of more than $1 million for September 2026, an increase of more

Healthcare IT Company and Nutritional Products Maker to Work with NFL Alumni Health to Drive Awareness of GLP-1 Telehealth and Pharmacy Services TAMPA, FL / ACCESS Newswire / September 28, 2026 / DataMeds AI, Inc. (NASDAQ:MEDS) ("DataMeds AI," "DataMEDS," or the "Company"), a healthcare company leveraging its Health IT and physical infrastructure together with its artificial intelligence platform EinsteinRx™ and smart contracts platform PharmacyChain™, and Tollo Health, LLC ("Tollo"), a healthcare company commercializing proprietary medical foods and dietary supplements and, through TolloBio, developing biopharmaceutical candidates, today announced the launch of the Health Lives Here m

Interim Co-CEO to Discuss Growing Patient Desire to Own Health Data TAMPA, FL / ACCESS Newswire / September 25, 2026 / DataMeds AI, Inc. (NASDAQ:MEDS) ("DataMeds AI," "DataMEDS," or the "Company"), a healthcare company leveraging its Health IT and physical infrastructure together with its artificial intelligence platform EinsteinRx™ and smart contracts platform PharmacyChain™,announced that its Interim Co-CEO Gerald Commissiong will present "What Patients Really Want" at this year's National Telehealth and Virtual Care Summit in Las Vegas on Monday, September 28, 2026 at 9:15am PT. Mr. Commissiong will discuss the growing desire by patients across the country to own their individual he

Rights offering to include both Common Unit and Preferred Unit subscription rights Moody Capital Solutions, Inc. to act as dealer manager of a rights offering open to all shareholders of the company Datavault AI Inc. (NASDAQ:DVLT) ("Datavault AI" or the "Company"), an Artificial Intelligence Platform ("AIP") company providing data monetization, credentialing and tokenization technologies, today announced that its board of directors (the "Board") has approved a rights offering to holders of its common stock ("Common Stock") and certain other Datavault AI securities. Moody Capital Solutions, Inc. ("Moody Capital") will act as dealer manager for the rights offering. The Rights Offering t

15th anniversary all-star showcase introduces a Bowl Combine that awards two roster spots and playing time to eligible student-athletes; game planned to be broadcast on ESPN PHILADELPHIA, PA / ACCESS Newswire / September 21, 2026 / Datavault AI Inc. ("Datavault AI" or the "Company") (NASDAQ:DVLT), a provider of data monetization, credentialing, digital engagement, and real-world asset ("RWA") tokenization technologies, today announced Dream Bowl XV. The game is the 15th anniversary edition of the premier college football all-star showcase for professional draft-eligible talent from all college divisions and NAIA programs. It will be held Sunday, January 17, 2027, at AT&T Stadium in Arl

Updated Website Aligns with Pending Marketing Initiatives Following Recent Acquisition of Helomics CLIA-certified Laboratory and Litigation Settlement TAMPA, FL / ACCESS Newswire / September 21, 2026 / DataMEDS AI, Inc. (NASDAQ:MEDS) (the "Company" or "DataMEDS"), a Health IT company vertically integrating health data acquisition and transfer, today announced that it launched its new corporate website www.DataMedsAI.com.This change comes following the recent announcement that DataMEDS has acquired Helomics Corporation's artificial intelligence (AI) Cancer Diagnostics Lab from Axe Compute, and that the Company settled outstanding litigation that resulted in the extinguishment of ~$19 mi

TAMPA, FL / ACCESS Newswire / September 18, 2026 / DataMeds AI, Inc. (NASDAQ:MEDS) ("DataMeds AI," "DataMEDS," or the "Company"), a healthcare company leveraging its Health IT and physical infrastructure together with its artificial intelligence platform EinsteinRx™ and smart contracts platform PharmacyChain™,today announced that it has settled litigation related to outstanding debt and receivables related to the May 11, 2023 Wellgistics, LLC Membership Purchase Interest Agreement (the "Settlement Agreement") that were previously carried on the Company's balance sheet as liabilities totaling of approximately $19 million. As part of the Settlement Agreement, the Company retired approximately

Order Marks the Commercial Opening of the Company’s Information Data Exchange, NILvault, and American Political Exchange Platforms LIVE TODAY | H.C. Wainwright 28th Annual Global Investment Conference Nathaniel Bradley, Co-Founder and CEO of Datavault AI Inc. (NASDAQ:DVLT), presents today, Tuesday, September 15, at 3:30 PM ET at the Lotte New York Palace Hotel in New York City. Datavault AI Inc. ("Datavault AI" or the "Company") (NASDAQ:DVLT), a provider of data monetization, credentialing, digital engagement, and real-world asset ("RWA") tokenization technologies, today announced that it has received an initial purchase order for $100 million of its $QEST tokenization services. The p

Company Remains Focused on Execution, Commercialization and Creating Long-Term Shareholder Value Datavault AI Inc. (NASDAQ:DVLT) ("Datavault AI" or the "Company"), an Artificial Intelligence Platform ("AIP") company focused on data monetization, credentialing, digital engagement, real-world asset ("RWA") tokenization and spatial audio technologies, today issued the following statement in response to recently filed shareholder litigation and related notices being circulated by plaintiffs’ law firms. Datavault AI is aware of the recently filed securities litigation against the Company and certain of its officers. The Company takes these matters seriously and intends to vigorously defend i